|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| (Income) loss on bank owned life insurance | |||||
| Provision for credit losses | |||||
| Net gain on sale of available-for-sale securities | |||||
| Income on bank owned life insurance | |||||
| Gain on sale of mortgage loans | |||||
| (Gain) loss on sale or disposal of premises and equipment | |||||
| Loss (gain) on sale of foreclosed real estate and repossessed assets | |||||
| Gain on sale or disposal of premises and equipment | |||||
| Gain on sale of other real estate owned | |||||
| Loss on settlement of bank owned life insurance | |||||
| Income on bank owned life insurance death benefit | |||||
| Loans originated for sale | |||||
| Proceeds from sales of loans originated for sale | |||||
| Net amortization/accretion of bond premiums/discounts | |||||
| Deferred tax benefit | |||||
| Net change in: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued interest payable | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Net increase in loans | |||||
| Purchase of securities available-for-sale | |||||
| Proceeds from repayments and maturities of securities available-for-sale | |||||
| Proceeds from sales of securities available-for-sale | |||||
| Redemption (purchase) of equity securities (restricted) | |||||
| Purchases of premises, equipment and software | |||||
| Proceeds from sale of premises and equipment | |||||
| Proceeds from sales of premises and equipment | |||||
| Proceeds from sales of other real estate owned | |||||
| Proceeds from settlement of bank owned life insurance | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Net change in short-term borrowings | |||||
| Net change in long-term debt | |||||
| Net change in noninterest-bearing deposits | |||||
| Net change in interest bearing deposits | |||||
| Net change in interest-bearing deposits | |||||
| Dividends paid | |||||
| Repurchase of common stock | |||||
| Net cash provided by financing activities | |||||
| Cash and Cash Equivalents, Beginning of the Year | |||||
| Cash and Cash Equivalents, End of the Year | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and and cash equivalents, beginning of the year | |||||
| Cash and cash equivalents, end of the year | |||||
| Supplemental disclosure of cash paid during the period for: | |||||
| Interest | |||||
| Taxes | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Change in unrealized losses on securities available for sale | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Transfer of loans to other real estate owned | |||||
| Real estate acquired in satisfaction of mortgage loans | |||||
| Cash surrender value of bank owned life insurance transferred to benefit receivable | |||||
| Change in unrealized losses on securities available-for-sale | |||||
Loading...